Osteoarthritis Therapeutics Market - Trends Forecast Till 2028

Osteoarthritis Treatment Market is segmented by Drugs (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Hyaluronic acid Injection, and Other Drugs), Anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis, and OtherAnatomies), and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: December, 2021

Base Year Estimate: 2020

Report ID: D-PH-OTM-790


Number of Pages: 380

Domain: Pharmaceutical

Osteoarthritis Therapeutics Market – Trends Forecast Till 2028

The Osteoarthritis Treatment Market is expected to witness a CAGR of 6.76% over the forecast period, 2021-2028.

Osteoarthritis, also known as degenerative arthritis, is the most commonly occurring chronic condition that affects the joints. This leads to severe joint pain and stiffness of the affected body parts. Osteoarthritis can be treated by several treatments, which include exercise for reducing joint pain, and pain medications.

The rising geriatric population, increasing incidence of osteoarthritis, and rising demand for minimally invasive surgical procedures are some of the factors that have supported long-term expansion for Osteoarthritis Therapeutics Market.

The market for osteoarthritis therapeutics is anticipated to be marginally affected due to the outbreak of COVID-19. Among drug types, the use of corticosteroids has reduced. Although there is no evidence to suggest that corticosteroid injections lead to a substantial increase in the risk of infection, there is a possible reduction in the immune response for up to a few weeks following the procedure.

Osteoarthritis Therapeutics Market Research Report

The North American market is expected to grow, owing to the increasing lifestyle changes, an increasing number of obesity cases, and an extensive rise in the geriatric population in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region.

Osteoarthritis Therapeutics Market is segmented into drugs, anatomy and region.

On the basis of Drugs

  • Non-steroidal Anti-inflammatory Drugs (NSAIDs)
  • Corticosteroids
  • Hyaluronic Acid Injection                     

On the basis of Anatomy

  • Ankle Osteoarthritis
  • Hip Osteoarthritis
  • Knee Osteoarthritis
  • Shoulder Osteoarthritis

On the basis of Region

  • Asia Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa

Insights are provided for each region and major countries within the regions

Osteoarthritis Therapeutics Market Primary Respondent


Key Players

  • Sanofi SA
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Zimmer Biomet
  • Abbott Laboratories
  • Bayer AG
  • Anika Therapeutics

Recent Developments

  • In December 2020, Moebius Medical received the US Food and Drug Administration (FDA) clearance for its investigational new drug (IND) application to initiate a global multi-center Phase IIb clinical trial of MM-II, which is a novel candidate for the treatment of pain due to knee osteoarthritis (OA).
  • In February 2020, Anika Therapeutics Inc. acquired Arthosurface, which led to the expansion of the joint preservation and restoration product portfolio.

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Osteoarthritis Therapeutics Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope


Report Feature


Growth Rate

CAGR of 6.76% during the forecasting period, 2021-2028

Historical Data


Forecast Years


Base Year


Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Drugs, anatomy and region.

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Sanofi SA, Pfizer Inc., GlaxoSmithKline plc, Zimmer Biomet, Abbott Laboratories, Bayer AG, and Anika Therapeutics.

Available Customization

In addition to the market data for Osteoarthritis Therapeutics Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.

Regional Report

Note: Report data and information will be by Country.

Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.